ArticleRMD open2025

Switching to biological DMARDs versus cycling among JAK inhibitors in patients with rheumatoid arthritis and with inadequate response to JAK inhibitors: from FIRST registry.

Yusuke Miyazaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.